Skip to main content

Table 2 Causes of service disruption described in the studies

From: Disruptions of neurological services, its causes and mitigation strategies during COVID-19: a global review

Reason of the disruption Number of studies (n = 240) (%) Studies focused on adults (n = 184) (%) Studies focused on children (n = 28) (%) Studies from HICs (n = 180) (%) Studies from LMICs (n = 30) (%)
Travel restrictions hindering patient access to health facilities 196 (81.7%) 149 (81.0%) 26 (92.9%) 146 (81.1%) 25 (83.3%)
Closure of inpatient and outpatient services or consultations as per health authority directive 157 (65.4%) 120 (65.2%) 23 (82.1%) 114 (63.3%) 20 (66.7%)
Decrease in outpatient volume due to patients not presenting 135 (56.2%) 113(61.4%) 13 (46.4%) 112 (62.2%) 15 (50%)
Decreased volume of patients due to cancellation of elective care 109 (45.4%) 79 (42.9%) 17 (60.7%) 77 (42.8%) 11 (36.7%)
Inpatient services and or hospital beds not available 52 (21.7%) 37 (20.1%) 7 (25.0%) 30 (16.7%) 7 (23.3%)
Clinical staff deployed and tasks shifted to provide COVID-19 clinical management or emergency support 40 (16.7%) 31 (16.8%) 3 (10.7%) 25 (19.2%) 5 (16.7%)
Unavailability or stock out of essential medicines, medical diagnostics or other health products at health facilities 40 (16.7%) 29 (15.8%) 3 (1.07%) 22 (12.2%) 7 (23.3%)
Insufficient PPE available for health care providers to provide services 22 (9.2%) 18 (9.8%) 1 (3.6%) 11 (6.1%) 3 (10%)
Insufficient staff to provide services due to staff illness/quarantine 11 (4.6%) 8 (4.3%) 1 (3.6%) 5 (2.8%) 2 (6.7%)
  1. Percentages are calculated over the 240 total studies that analyzed disruption of neurological services, and over the total number of studies that assessed only adults (n = 184) or only children (n = 28); and over the total number of studies from high-income countries (HICs) (n = 180) or low–middle-income countries (LMICs) (n = 30)